TipRanks
Go Ultimate55% OFF

Thomas W. Beetham Insider Profile

11 Followers

Thomas W. Beetham, COO at Viridian Therapeutics, holds 13.27K shares in Viridian Therapeutics (Ticker: VRDN), holds 19.90K shares in Dianthus Therapeutics (Ticker: DNTH), holds 297.52K shares in Kiniksa Pharmaceuticals (Ticker: KNSA).

Thomas W. Beetham's Trading History

VRDN
Viridian Therapeutics
Mar 04, 2026COOUninformative Buy183.87K$335.76K
DNTH
Dianthus Therapeutics
Dec 02, 2022CLO and SecretaryUninformative Buy2.82K$1.64M
KNSA
Kiniksa Pharmaceuticals
Feb 05, 2021EVP & CLOUninformative Sell54.72K$27.02M

You May Also Like

Thomas W. Beetham insider profile FAQ

What stocks does Thomas W. Beetham hold?
Thomas W. Beetham holds: VRDN, KNSA, DNTH stocks.
What was Thomas W. Beetham’s latest transaction?
Thomas W. Beetham’s latest transaction was an Uninformative Buy of $183.87K.
What is Thomas W. Beetham's role in Viridian Therapeutics?
Thomas W. Beetham's role in Viridian Therapeutics is COO.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.

TipRanks measures corporate insiders by the stock transactions they report to the SEC. See how TipRanks ranks experts and calculates performance.